Table 1.
Demographic, clinical, and volumetric information of the participants
| Healthy Control (n = 20) |
LTLE (n = 11) | RTLE (n = 8) | |
|---|---|---|---|
| Age | 42.26 (15.80) | 39.93 (11.54) | 33.00 (14.56) |
| Education | 15.85 (2.25) | 14.27 (1.74) | 14.00 (2.73) |
| BDI-II | 5.1 (6.05) Range: 0 – 21 |
10.82 (7.36) Range: 1 – 21 |
9.86 (7.71) Range: 0 – 18 |
| Age of Onset | - | 17.50 (15.17) | 20.00 (11.24) |
| Disease Duration | - | 21.86 (17.01) | 12.75 (13.60) |
| Left Hippocampus Volume | 3947.10 (368.88) | 3359.09 (789.98)* | 3975.25 (611.36) |
| Right Hippocampus Volume | 3987.40 (366.37) | 3980.55 (335.42) | 3418.38 (1183.00) |
| Left Amygdala Volume | 1526.25 (247.17) | 1443.27 (358.29) | 1669.88 (256.47) |
| Right Amygdala Volume | 1720.15 (247.63) | 1774.36 (266.75) | 1743.50 (488.20) |
| Hippocampal Asymmetry | −.01 (.05) | −.18 (.19)*^ | .20 (.26)^ |
| Amygdala Asymmetry | −.12 (.13) | −.22 (. 17)^ | −.02 (.20)^ |
Note:
*
denotes a patient group showing statistically significant difference from the control group at alpha of .05.
^
denotes LTLE and RTLE significantly different from each other at alpha of .05 Although the RTLE group show larger left hippocampal volume than the healthy control, the difference did not reach statistical significance, and by removing one outlier from RTLE group, their left hippocampal volume is smaller than healthy controls.